Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

CACNA1S Gene: Thyrotoxic Periodic Paralysis Type 1 Genetic Test in UAE | 2800 AED

Executive Summary & Core Metrics

Accuracy Guarantee

99.9% Diagnostic Sensitivity via ISO‑Accredited Next‑Generation Sequencing (NGS)

Premium Logistics

VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)

Clinical Guidance

Telephonic Post‑Test Clinical Guidance in Result Interpretation – empowering you with expert insights.

Insurance & Billing

Direct Billing Verification via WhatsApp: +971 54 548 8731

Legal Compliance: Aligned with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139.

Test Overview & Methodology

The CACNA1S gene NGS test identifies pathogenic variants responsible for thyrotoxic periodic paralysis type 1, a rare autosomal dominant muscle channelopathy that causes episodic weakness triggered by thyrotoxicosis. The test covers all coding exons and splice sites to provide a definitive molecular diagnosis.

Our Test vs. Closest Alternative
Parameter Our Precision NGS Targeted Mutation Screening
Precision >99.9% sensitivity for all coding/ splicing variants Limited to predefined hotspots
Method Next Generation Sequencing (NGS) Sanger sequencing / PCR panel
Turnaround 3–4 Weeks 4–6 Weeks

Physician Insight & Safety Protocols

From Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403): “This test is a powerful tool for confirming the genetic basis of thyrotoxic periodic paralysis. I guide patients through the implications of their results, always alongside a complete clinical and family history review. My goal is to provide clarity and a roadmap for personalised treatment, not to create uncertainty.”

Safety Advisory

Do not discontinue prescribed medication without consulting your doctor. Thyrotoxicosis treatment requires close supervision; abruptly stopping anti‑thyroid drugs or beta‑blockers can precipitate a severe paralytic episode.

Exclusion Criteria & Emergency Red Flags

  • Exclusion: Known non‑thyrotoxic hypokalemic periodic paralysis (e.g., Andersen‑Tawil syndrome); pregnancy – genetic testing only after careful risk‑benefit evaluation.
  • ER Red Flags: Sudden, severe limb paralysis or difficulty breathing, cardiac palpitations/arrhythmia, or a drop in potassium below 2.5 mmol/L during an attack – seek emergency medical attention immediately.

Patient FAQ & Clinical Guidance

1. What does the CACNA1S gene test involve?

A simple blood draw or dried blood spot sample is collected via VIP Mobile Phlebotomy at your home, then analysed by NGS for pathogenic variants across the entire coding region.

2. How accurate is this genetic test?

Our ISO‑accredited laboratory delivers 99.9% diagnostic sensitivity for detecting known and novel CACNA1S mutations, providing a near‑definitive molecular diagnosis.

3. Is genetic counselling required before the test?

Yes, a pre‑test genetic counselling session is mandatory per DHA guidelines to discuss implications and draw a family pedigree. This ensures informed consent and proper interpretation.

UAE Regulatory & Data Privacy Adherence

Legal Framework Compliance

This genetic test is conducted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted and processed under strict confidentiality. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name CACNA1S Gene: Thyrotoxic Periodic Paralysis Type 1 Genetic Test
Price (AED) 2,800
Turnaround Time 3–4 weeks
Sample Type / Matrix Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)
Methodology Used Next-Generation Sequencing (NGS)
ICD-10-CM Code G72.3
LOINC Code 48019-1
DHA Facility License & Laboratory Address License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians